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ABSTRACT  
Diabetes is a notorious and growing clinical and public health issue. The International Diabetes Federation assumes that 592 million had 
diabetes by 2035 and that by 2040 the number will increase to 642 million. Cardiovascular corollary accounts for four million deaths annually 
attributable to diabetes. Evidence reveals that certain glucose-lowering phytochemicals can improve vascular outcomes with type 2 diabetes, 
which, together with better understanding of using multiple therapies concurrently, offers opportunities for beneficial personalization of 
medication regimens. Anthocyanins are coloured pigments and are natural antioxidants. Keeping this in focus, this study was undertaken to 
evaluate the in vitro antidiabetic activity in the petals of wild Impatiens balsamina L. The anthocyanin was extracted from floral petals of wild 
balsam species and purified to homogeneity using chromatographic techniques. Evaluation of in vitro antidiabetic properties of anthocyanin 
extract revealed a dose-dependent increase in the inhibitory effect on the alpha-glucosidase (200 μg/ml) and alpha-amylase enzymes (500 
μg/ml) and was comparable with the standard acarbose drug (189 μg/ml and 50 μg/ml). These results indicated that anthocyanin could be 
used as a source of functional food and nutraceuticals. This information from wild species will be useful in finding more potent antidiabetic 
principle from the natural resources for the clinical development of antidiabetic therapeutics. Future studies are planned to substantiate the 
antidiabetic power of anthocyanin using in vivo animal models. 
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1. INTRODUCTION 
Currently, million in the earth suffered from diabetes as per 
the public health1. Further, the chance of diabetes is 
predicted to boom to 592 million by 2035. It is one of the life 
style disorders that causes increasing mortality and is a 
global health issue of which type 2 diabetes (T2D) 
accounting 90%2. It featured by hyperglycemia, will cause a 
severe metabolic disorder in glucose, lipid and protein 
levels. Furthermore, type 2 diabetes is also connected with 
many disorders such as nephropathy and cardiovascular and 
cerebro-vascular diseases3. Most of the diabetics possess 
hyperlipidemia i.e., blood has too many lipids (or fats), such 
as cholesterol and triglycerides. Moreover, many 
documented the induction of oxidative stress related to 
diabetes. Hyperglycemia induces reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) will damage the 
pancreatic islet β-cell and their by insulin level. Insulin 
resistance and islet β-cell dysfunction are the critical reasons 
for diabetes, and therefore, mitigating oxidative stress to 
protection the cells may be an ideal way for T2D treatment. 
Nutraceutical along with drug therapy has been an effective 
strategy against diabetes.  
Anthocyanins are flavonoid group of aqueous natural 
pigments exist in plants widely. They display antioxidant, 
anti-inflammatory, bactericidal, antiaging, antimetastatic, 
and protective effects on the liver, cardiovascular and 
cerebrovascular, and vision. Currently, synthetic drugs with 
antidiabetic effects like sulfonylureas, biguanides, and α-
glucosidase inhibitors groups are being used orally. The 
therapeutic support usage has multiple side effects like 
weight gain, hypoglycemia, gastrointestinal disturbances, 
liver and kidney damage, and hypersensitivity reactions 
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which may have a negative impact on the response to 
treatment4. The high cost of antidiabetic therapies together 
with the myriad of adverse effects prompted the exploration 
of cheaper and more effective antidiabetic biomolecules 
from medicinal herbals. Some researchers suggested that the 
anthocyanins extract inhibits alpha amylase action, 
indicating that the molecules have unique function to 
suppress the increase in postprandial glucose content from 
starch5, 6. The present study is aimed to investigate in vitro 
antidiabetic activities of the purified anthocyanin of wild 
Balsam species based on local claims regarding its use in the 
treatment of diabetes. 
2. MATERIALS AND METHODS 
2.1 Plant materials  
For the whole study, the fresh healthy flowers of Impatiens 
balsamina L. (wild) collected from the natural habitats of 
hilly regions of Trivandrum, Kerala. 
2.2 Estimation of anthocyanin content  
1g flower was homogenized with acidified methanol (1% 
HCl) and the anthocyanin content was quantified by the 
standard protocol of Sutharut and Sudarat7. The absorbance 
of each dilution was read at 510 and 700 nm against distilled 
water as blank. 
2.3 Purification and characterization of anthocyanin 
from wild balsam  
Anthocyanin from fresh flowers of wild Balsam was 
extracted by acidified methanol (100% Methanol: 1% HCl, 
99:1, v/v) i.e., the petals were immersed in acidified 
methanol for overnight in dark at low temperature (4ºC). 
Subsequently, the crude solution obtained was filtered 
through cheese cloth and concentrated in rotary vacuum 
evaporator under vacuum at temperature not exceeding 
400C. Then the aqueous extract was partitioned with ethyl 
acetate and the remaining water extract was concentrated in 
rotary vacuum evaporator, temperature not exceeding 40ºC. 
It was further fractionated by using Sephadex LH-20 
followed by C18 as separation matrices. The aqueous extract 
was loaded on to a Sephadex LH-20 using 100% methanol. 
Based on the TLC profile the fractions were subjected to 
purification by C-18 open-column chromatography using 
acidified water (1% HCl) and the column was eluted with a 
gradient of acidified methanol (1% HCl) and water [0:100 to 
50:50]. From RP C-18 open-column chromatography, based 
on the TLC profile the pure fractions were concentrated and 
kept at low temperature (-200C). Purified anthocyanin from 
the wild Balsam was subjected to NMR analysis for their 
structural identification. 
2.4 In vitro antidiabetic activities 
2.4.1 In vitro α-glucosidase inhibition assay 
The α-amylase and α-glucosidase inhibitory effect of plant 
extracts was determined according to the protocol of Kim et 
al8. For alpha glucosidase inhibition, yeast α-glucosidase was 
dissolved in 100 mM, pH 7.0 phosphate buffer, containing 
bovine serum albumin 2 g/l and sodium azide 0.2 g/l which 
was used as source of enzyme. Substrate used was para-
nitrophenyl-α-d-glucopyranoside. Extract was weighed and 
serial dilutions of 50, 100, 200, 400 and 500 μg/mL were 
made up with equal volumes of dimethylsulfoxide and 
distilled water. 10 μl of extract dilutions was incubated for 5 
min with 50 μl enzyme source. After incubation, 50 μl of 
substrate was added and again incubated for 5 min at room 
temperature. The pre-substrate and post -substrate addition 
absorbance was recorded at 405 nm on a microplate reader. 
The increase in OD on substrate addition was obtained. Each 
test was carried thrice and the mean OD was used to 
quantify the percentage of α-glucosidase inhibition. 
Acarbose was used as positive control with different doses. 
The dosage of acarbose and anthocyanin extract required to 
inhibit 50% of α-amylase activity under the conditions was 
noted as the IC50 value. 
Percentage α-glucosidase inhibition was calculated 
according to the formula: 
Percentage of inhibition = [(Control 405 - Extract 405)]  X 100 
                                                                      Control 405 
2.4.2 In vitro alpha amylase inhibition assay 
The assay was performed following the method of 
Hansawasdi et al 9. 2 mg Starch azure was suspended in 0.2 
mL of Tris-HCl buffer (pH 6.9, 0.5 M) containing CaCl2 (0.01 
M, substrate). The tubes containing substrate solution were 
heated for 5 min and then pre-incubated at 37ºC for 5 min. 
Purified anthocyanin extract from wild balsam species was 
dissolved in DMSO in order to obtain various doses of 50, 
100, 200, 400 and 500 μg/mL. Anthocyanin extract of 
particular concentration was added to the tube containing 
the substrate solution. In addition, 0.1 mL of porcine 
pancreatic amylase in Tris-HCl buffer (2 U/mL) was also 
added. The reaction was carried out at 37ºC for 10 min. The 
reaction was arrested by adding 0.5 mL of 50% acetic acid in 
each tube. The reaction mixture was centrifuged at 3000 
rpm for 5 min at 4ºC. The OD of resulting supernatant was 
recorded at 595 nm. Acarbose, a known α-amylase inhibitor 
was used as a standard drug. The experiments were 
repeated three times. The α-amylase inhibitory activity was 
calculated by using the following formula: 
The α-amylase inhibitory activity =  
[(Ac+ - Ac-) - (As - Ab)]/(Ac+) - (Ac-) Χ 100, 
where Ac+, Ac-, As, and Ab are the absorbance of 100% 
enzyme activity (only solvent with enzyme), 0% enzyme 
activity (only solvent without enzyme), a test sample (with 
enzyme), and a blank (a test sample without enzyme), 
respectively. The concentration of acarbose and anthocyanin 
extract required to inhibit 50% of α-amylase activity under 
the conditions was defined as the IC50 value. 
2.5 Statistical analysis 
SPSS 18.0 statistical software was used for data analysis. 
Data from different assay treatments were analyzed by one-
way analysis of variance (ANOVA); The Student-Neuman-
Keuls post-hoc test was used to determine significance for 
individual experimental conditions. Differences with P < 
0.01 or P < 0.05 were regarded as significant. 
3. RESULTS AND DISCUSSION 
3.1 Anthocyanin content, purification and fractionation 
Anthocyanin content in the petals of wild Balsam species 
was quantified as 5.88 mg/g. Purified anthocyanins after 3 
step protocol was subjected to NMR and LC MS analysis 
(Fig.1, 2, 3) for their structural identification. The major 
fractions were hesperidin, dimethoxy antirrhinin and 
trimethoxy antirrhinin (Fig. 4: A, B, C). 
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Fig. 1: (a) LC MS and (b) NMR spectrum of Hesperi1din from the wild Balsam 
   
Fig. 2: (a) LC MS and (b) NMR spectrum of Dimethoxy antirrhinin from the wild Balsam 
   
Fig. 3: (a) LC MS and (b) NMR spectrum of Trimethoxy antirrhinin from the wild Balsam. 
             
Fig. 4: Chemical structure of (A) Hesperidin (C28H34O15) (B) Dimethoxy antirrhinin (C29H35ClO15) (C) Trimethoxy antirrhinin 
(C30H37ClO15) 
3.2 In vitro Antidiabetic Activity 
3.2.1 In vitro α-amylase inhibitory activity  
The in vitro α-amylase inhibitory potentiality of the purified 
anthocyanin extracts of wild balsam species was evaluated. 
The data displays a dose-dependent increase in the 
percentage of inhibitory activity against the α-amylase 
enzyme. The purified anthocyanin extract (50, 100, 200, 400 
and 500 μg/ml) of wild balsam exhibited potent α-amylase 
inhibitory activity from 24.2 to 80.7% with an IC50 value of 
200 μg/ml extract (Table 1). Acarbose, the standard drug for 
α-amylase inhibitor at a concentration of 50-500 μg/ml, 
showed α-amylase inhibitory activity from 27.1 to 83.2% 
with an IC50 value 189 μg/ml extract. So, it is possible to 
suggest that the extract may be used as starch blockers since 
it inhibits or delays the starch absorption into the body 
mainly via blocking the lysis of 1,4-glycosidic linkages of 
starch and other oligosaccharides into maltose, maltotriose 
and other sugars. In the present study, the extract of wild 
balsam showed maximum α- amylase inhibitory activity (IC50 
= 200 μg/ml extract) which could be attributed by the 
purified anthocyanin (5.88 mg/g). It is possible to suggest 
that polyphenolics are not only capable of mitigating 
oxidative stress but also inhibits carbohydrate hydrolyzing 
enzymes due to their ability to bind with proteins. The 
obtained results were in accordance with the studies in the 
species such as Vietnamese edible plants, Gymnema 
montanum, and Psidium guajava leaves respectively10, 11, 12.  
b a 
a 
b 
a b 
A B C 
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Table 1. In vitro α-amylase inhibitory potentiality of the purified anthocyanin extracts of wild balsam species 
Concentration (µg/mL) Percentage inhibition 
Anthocyanin Standard: Acarbose 
50 24.2 27.1 
100 39.60 33.31 
200 50.0 56.48 
400 63.92 73.12 
500 80.7 83.2 
 
3.2.2 In vitro α-glucosidase inhibitory activity  
Antidiabetic activity using α- glucosidase inhibitory assay of 
the purified anthocyanin extracts was narrated in the Table 
2. The anthocyanin extract showed remarkable inhibitory 
action of α-glucosidase enzyme. The percentage of inhibition 
at 50-500 μg/ml concentrations of wild balsam anthocyanin 
extract showed a concentration dependent increase in 
inhibition. 
 
Table 2. In vitro α-glucosidase inhibitory potentiality of the purified anthocyanin extracts of wild balsam species 
Sample concentration (µg/mL) Percentage inhibition 
Anthocyanin Standard: Acarbose 
50 18.5 50.01 
100 30.20 65.51 
200 34.40 68.66 
400 38.02 74.72 
500 50.03 85.27 
  
The percentage of inhibition varied from 18.5 – 50.03% for 
highest concentration to the lowest dose with an IC50 value 
500 μg/ml. Thus the inhibition of the activity of α-
glucosidase by anthocyanin would retard the carbohydrate 
degradation which in turn reduce the absorption of glucose, 
as a result the reduction of post-prandial blood glucose level 
elevation.  
In this study, the standard drug acarbose for the α-
glucosidase inhibitor at a concentration of 50-500 μg/ml 
showed α-glucosidase inhibitory activity from 59.28 to 
85.27% with an IC50 value 50 μg/ml. This indicates that the 
anthocyanin is potent α-amylase and α-glucosidase inhibitor 
and comparable with acarbose. Thus, there is a positive 
relationship between the polyphenol content and their 
ability to inhibit intestinal α-glucosidase and pancreatic α-
amylase. 
Lee et al screened antidementia acetylcholinesterase 
inhibitors from the fruits and designed an optimal extraction 
conditions13. In vitro antidiabetic and antioxidant activities of 
methanol extract of Tinospora sinensis was described14. 
Antihyperglycemic, antidiabetic, and antioxidant effects of 
Garcinia pedunculata in rats was also proved15. Different 
studies have reported that dietary polyphenols including 
flavonoids and phenolic acids may inhibit 𝛼-amylase and 𝛼-
glucosidase which inturn inhibit glucose absorption in the 
intestine by sodium-dependent glucose transporter 1 
(SGLT1), stimulate insulin secretion, and reduce hepatic 
glucose output. Polyphenols may also increase insulin-
dependent glucose uptake, activate 5’ adenosine 
monophosphate-activated protein kinase (AMPK), modify 
the microbiome, and have anti-inflammatory effects. Detailed 
experimentation should be conducted to identify the exact 
mechanism. Some researchers showed that catechin 
treatment ameliorates diabetes and its complications in 
streptozotocin-induced diabetic rats16. Madhuri and Naik 
analyzed modulatory effect of garcinol in streptozotocin-
induced diabetic Wistar rats17. Some studies documented in 
vitro antioxidant, antidiabetic, cholinesterase and tyrosinase 
inhibitory potential of fresh juice from Citrus hystrix and C. 
maxima fruits18. Ocimum genera have been reported to have 
antidiabetic potentials. O. basilicum, O. tenuiflorum, O. 
sanctum, O. canum leaves have all been reported to exhibit 
strong inhibition against α-amylase and α- glucosidase19. 
Studies revealed the preventive effects of Morus alba 
anthocyanins on diabetes in Zucker diabetic fatty rats20. It 
was proposed that inhibition of the activity of such alpha-
amylase and alpha-glucosidase would delay the degradation 
of carbohydrate, which would in turn cause a decrease in the 
absorption of glucose, as a result the reduction of 
postprandial blood glucose level elevation21. The antidiabetic 
and antioxidative potential of the blue congo variety of 
purple potato extract in streptozotocin-induced diabetic rats 
was explained22. Sundarrajan et al studied in-vitro 
hypoglycemic and glucose uptake activity of isolated 
compound from ethanolic leaf extract of Amaranthus tristis23. 
Researchers showed in vitro antidiabetic activity affecting 
glucose uptake in Hep G2 cells following their exposure to 
extracts of Lauridia tetragon24. Antidiabetic effect of 
ethanolic leaf extract of Phyllanthus amarus in alloxan 
induced diabetic mice was studied25. Recently, evaluated of 
hypoglycemic and antihyperglycemic effect of aqueous-
methanolic leaves extract of two medicinal plants of 
Meghalaya in mice26. Similarly, confirmed the antidiabetic 
and antiobesity effects of plant extract from Cleome 
droserifolia27. The antidiabetic activity of Terminalia catappa 
leaf extracts in alloxan-induced diabetic rats was also 
proved28. 
Antidiabetic activity of selected herbals such as bark of 
Eugenia jambolana, the whole plants of Phyllanthus niruri, 
seeds of Momordica charantia and leaves of Nyctanthes 
arbor-tristis was investigated. The results revealed that the 
aqueous extract showed better efficacy than the ethanolic 
extracts in all the treated extract in lowering the blood 
glucose levels in alloxan induced diabetic rats29. In vitro 
antioxidant and antidiabetic activity of methanolic fruit 
extract of medicinal plant Piper cubeba was evaluated. The 
treatment of the yeast cells with the methanolic extract 
revealed that the glucose uptake was found to increase in a 
dose dependent manner which amplifies its antidiabetic 
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potentiality. This probable attribute is due to the bioactive 
polyphenols and flavonoids in the extract30. Thus, the 
obtained data in this study substantiates the antidiabetic 
possibilities of anthocyanins from the wild balsam species. 
This is the first report of in vitro antidiabetic activity of 
anthocyanin from the species.  
4. CONCLUSION 
The results of the present study showed that the wild balsam 
possess optimal level of anthocyanin content. In vitro alpha 
amylase and alpha glucosidase activity of anthocyanin from 
the I. balsamina floral extract was evaluated. Anthocyanin of 
Balsam species has been traditionally used as herbal 
medicine in folk remedies for curing multiple ailments. So, 
further in vivo studies are warranted to declare the 
anthocyanin of Balsam species as novel antidiabetic target 
for new drug designing. 
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